Dr. Prasanth Manohar, Ph.D., – Page 38 – PHAGElogist

The secret social lives of viruses

Scientists are listening in on the ways viruses communicate and cooperate. Decoding what the microbes are saying could be a boon to human health. Geneticist Rotem Sorek could see that…

Shrimp bacteriophage nears commercial launch, Tamil Nadu, India

Scientists in India have developed a bacteriophage-based product to help control bacterial diseases in shrimp hatcheries. At a time when bacterial disease is posing a major threat to shrimp seed…

Home hygiene contributing to antibiotic resistance

Hygiene experts have said that poor hygiene in the home is contributing to antibiotic resistance. The Global Hygiene Council conducted a risk-based approach to home hygiene, concluding that good hygiene in the…

COVID-19 related antimicrobial resistance challenges and opportunities

Challenges •Resources directed away from AMR surveillance•Increase in pre-emptive antibiotic prescribing to prevent secondary bacterial infections•Antibiotic overuse in agribusiness•Delays in AMR legislation•Antimicrobial drug shortages•Empty pharmaceutical pipeline•USA withdrawal of support for…

Tracking the Global Pipeline of Antibiotics in Development

Drug-resistant bacteria, or superbugs, present a serious and worsening threat to human health. According to a report from the Centers for Disease Control and Prevention, 2.8 million Americans acquire serious infections caused…

Gold Chance for Bacteriophage Researchers: Journal Publication

Antibiotics (mdpi publisher) In light of your outstanding expertise, we would like to cordially invite you to contribute a paper to be included in the Special Issue “Phage Therapy to Control…

Treating Covid-19 may lead to increased antibiotic resistance

Patients hospitalised due to the novel coronavirus infection are being given a combination of medications to prevent possible secondary bacterial infections, noted the researchers at the University of Plymouth in…

Researchers Advance the Fight Against Antibiotic Resistance

Each year, about 2.8 million Americans get bacterial infections that resist treatment by the antibiotics designed to knock them out. About 35,000 of those patients die – globally the mortality…

Intravesical bacteriophages for treating urinary tract infections

Published in the Lancet Infectious Diseases Background Urinary tract infections (UTIs) are among the most prevalent microbial diseases and their financial burden on society is substantial. In the context of…

Bacteriophages could combat secondary COVID-19 infections

New research suggests that bacteriophage therapy could counteract the risk of secondary bacterial infections, which affect some patients with weakened immune systems after being infected with the SARS-CoV-2 coronavirus.A study…